GCP
FMI

GSA Capital Partners’s Foundation Medicine, Inc. FMI Stock Holding History

GSA Capital Partners’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,400
Closed -$601K – 2079
2018
Q2 		$601K Buy
+4,400
New +$400K 0.03% 1066
2017
Q1 		– Sell
-11,500
Closed -$204K – 2150
2016
Q4 		$204K Buy
11,500
+2,234
+24% +$48.1K 0.01% 1589
2016
Q3 		$216K Buy
+9,266
New +$210K 0.01% 1564
2014
Q4 		– Sell
-11,100
Closed -$210K – 2017
2014
Q3 		$210K Buy
11,100
+3,400
+44% +$81.1K 0.01% 1498
2014
Q2 		$208K Buy
+7,700
New +$195K 0.01% 1606

GSA Capital Partners's FMI Position: Q3 2018 in Review

GSA Capital Partners sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 4,400 shares — an estimated $601K sold.

GSA Capital Partners first reported a position in FMI in Q2 2014 and held it in 5 quarters. The position peaked at $601K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • GSA Capital Partners reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • GSA Capital Partners sold 4,400 Foundation Medicine, Inc. shares in Q3 2018, an estimated $601K.
  • GSA Capital Partners first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 5 quarters.
  • GSA Capital Partners's Foundation Medicine, Inc. position peaked at $601K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on GSA Capital Partners's 13F filing for Q3 2018, filed 13 Nov 2018.